Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oncothyreon Inc (NASDAQ:ONTY)

3.25
Delayed Data
As of Sep 04
 -0.10 / -2.99%
Today’s Change
1.41
Today|||52-Week Range
4.69
+71.05%
Year-to-Date
No recent news for Oncothyreon Inc.

Today’s Trading

Previous close3.35
Today’s open3.29
Day’s range3.22 - 3.38
Volume515,073
Average volume (3 months)1,389,306
Market cap$317.9M
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-3.23%
Earnings growth (this year)+42.19%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.36

Competitors

 Today’s
change
Today’s
% change
BSTCBiospecifics Technol...+1.64+3.49%
ARWRArrowhead Research C...+0.04+0.73%
NVIVInVivo Therapeutics ...+0.37+3.90%
ZYNEZynerba Pharmaceutic...+0.02+0.07%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$0.00
Annual profit (last year)-$50.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert L. Kirkman
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts

Partner Offers